Peptide Synthesizers Market to Observe Strong Development by 2025

Peptides are chains of amino acids, which are building blocks of all major living organisms. In-vitro production of peptides can be achieved by using individual amino acids and binding them in accordance with the desired sequence in a controlled environment. Earlier, synthetic peptides were produced by using the liquid phase method, which was largely replaced by the solid phase method. Before introduction of peptide synthesizer systems, in-vitro synthesis of peptides was a time-consuming process involving complexity, highly skilled operators, and high consumption of resources. Peptide synthesizers offer ability to build and synthesize complex peptides in a short time from research scale to production scale. Moreover, advanced peptide synthesizers can synthesize multiple peptides at the same time. Synthetic peptides are used to produce specific antibody epitopes and enzyme-binding sites and for designing and development of drugs, vaccines, and enzymes.

Changing landscape of the health care industry with a higher focus on developing novel therapeutics for diseases and disorders is anticipated to increase investments in research and development programs in public as well as industry sectors. This is estimated to drive the Peptide Synthesizers Market during the forecast period from 2017 to 2025. Additionally, growing inclination in the pharmaceutical industry toward biosimilars and peptide therapeutics is projected to fuel the market. Growing parasitic & viral infections across the globe and increasing prevalence of chronic diseases are likely to rise demand for new diagnostic tools using specific antibodies. This is projected to rise in vitro peptide synthesis, driving global peptide synthesizers market in the near future.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32282

Besides pharmaceutical and health care sectors, consumption of synthetic peptides is rising in industries such as food & beverages, biosensors, and environment. Synthetic peptides are used for R&D and production purposes in these industries. This factor is estimated to drive the peptide synthesizers market during the forecast period. However, high cost of peptide synthesizer systems and its consumables is projected to restrain the market between 2017 and 2025. Availability of customized peptide synthesis services and increasing use of bio-simulation software are some more factors estimated to restrain the global peptide synthesizers market from 2017 to 2025.

The global peptide synthesizers market can be segmented on the basis of product, technology, system capacity, end-user, and region. In terms of product, the market can be divided into single channel and multi-channel. Ability to synthesize complex peptides simultaneously is estimated to be a driving factor for the multi-channel segment of the peptide synthesizers market in the near future. In terms of technology, the market can be segregated into manual, semi-automatic, and automatic peptide synthesizers. In terms of capacity, the market can be categorized into low-throughput and high-throughput peptide synthesizers. Increasing usage of synthetic peptides in pharmaceutical and diagnostics industries is likely to drive the high-throughput peptide synthesizers segment in the near future. Based on end-user, the market for peptide synthesizers can be segmented into academic research institutes, pharmaceutical & biotechnology industry, and others. Increasing investments in research and development in pharmaceutical, food & beverages and life sciences industry; and the rising number of contract research organizations are likely to propel the pharmaceutical & biotechnology industry segment during the forecast period.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=32282

Geographically, the global peptide synthesizers market has been divided into North America, Europe, Asia Pacific, and Rest of World. High adoption of technology and high expenditure by both public and private sectors on R&D are factors likely to contribute to high share held by North America in the global market. Europe is anticipated to account for a significant share of the global market during the forecast period, due to well-established pharmaceutical & biotechnology industry in the region. Increasing base on contract research organizations and academic research institutes in emerging markets such as China and India is likely to fuel the market in Asia Pacific during the forecast period.

Major players operating in the global peptide synthesizers market are AAPPTec, LLC, Biotage, CSBio Company Inc., GYROS PROTEIN TECHNOLOGIES AB, Activotec, HB Technologies AG (Intavis), Thermo Fisher Scientific, CEM Corporation, Shimadzu Corporation, PerSpective Biosystems, Inc., and Advanced ChemTech Inc.

View Report -

https://www.transparencymarketresearch.com/peptide-synthesizers-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.